Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATG3P1 (autophagy related 3 pseudogene 1) is a processed pseudogene located on chromosome 20q12[3]. It is a non-protein-coding genomic DNA segment derived from the functional autophagy related 3 (ATG3) gene. Unlike the active ATG3 gene, which encodes a key enzyme in the autophagy pathway, ATG3P1 does not translate into a protein product and has no established biological function, disease association, or direct therapeutic relevance. Its designation as "pseudogene" indicates it is generally regarded as a genomic relic, though some pseudogenes have been implicated in regulatory mechanisms in rare cases. The standard gene alias for ATG3P1 is dJ54G6.1[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Autophagy related 3 pseudogene 1 (ATG3P1).